Experiences of Using Misoprostol in the Management of Incomplete Abortions: A Voice of Healthcare Workers in Central Malawi.
experiences
incomplete abortion
misoprostol
post-abortion care
service providers
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
23 09 2022
23 09 2022
Historique:
received:
13
08
2022
revised:
20
09
2022
accepted:
21
09
2022
entrez:
14
10
2022
pubmed:
15
10
2022
medline:
18
10
2022
Statut:
epublish
Résumé
Complications after abortion are a major cause of maternal death. Incomplete abortions are common and require treatment with surgical or medical uterine evacuation. Even though misoprostol is a cheaper and safer option, it is rarely used in Malawi. To improve services, an intervention was performed to increase the use of misoprostol in post-abortion care. This study explored healthcare providers' perceptions and experiences with misoprostol in the Malawian setting and their role in achieving effective implementation of the drug. A descriptive phenomenological study was conducted in three hospitals in central Malawi. Focus group discussions were conducted with healthcare workers in centres where the training intervention was offered. Participants were purposefully sampled, and thematic analysis was done. Most of the healthcare workers were positive about the use of misoprostol, knew how to use it and were confident in doing so. The staff preferred misoprostol to surgical treatment because it was perceived safe, effective, easy to use, cost-effective, had few complications, decreased hospital congestion, reduced workload, and saved time. Additionally, misoprostol was administered by nurses/midwives, and not just physicians, thus enhancing task-shifting. The results showed acceptability of misoprostol in post-abortion care among healthcare workers in central Malawi, and further implementation of the drug is recommended.
Identifiants
pubmed: 36231358
pii: ijerph191912045
doi: 10.3390/ijerph191912045
pmc: PMC9565130
pii:
doi:
Substances chimiques
Misoprostol
0E43V0BB57
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
PLoS One. 2019 Jan 10;14(1):e0210449
pubmed: 30629715
Health Hum Rights. 2019 Dec;21(2):145-155
pubmed: 31885444
Taiwan J Obstet Gynecol. 2019 Nov;58(6):748-756
pubmed: 31759522
Health Policy Plan. 2017 Apr 1;32(3):305-313
pubmed: 27616307
Midwifery. 2019 Oct;77:71-77
pubmed: 31255911
BMC Health Serv Res. 2014 Jan 21;14:28
pubmed: 24447321
PLoS One. 2017 Apr 3;12(4):e0173639
pubmed: 28369114
PLoS One. 2014 Jun 25;9(6):e100728
pubmed: 24963882
Sultan Qaboos Univ Med J. 2019 Feb;19(1):e38-e43
pubmed: 31198594
Int J Gynaecol Obstet. 2015 Feb;128(2):160-4
pubmed: 25468057
PLoS One. 2016 Feb 12;11(2):e0149172
pubmed: 26872219
BMJ Open. 2017 Oct 10;7(10):e016157
pubmed: 29018067
Int J Environ Res Public Health. 2021 Oct 07;18(19):
pubmed: 34639806
BMC Health Serv Res. 2015 Dec 17;15:562
pubmed: 26677840
Health Care Women Int. 2020 Jul;41(7):732-760
pubmed: 31855511
Int J Environ Res Public Health. 2018 Feb 21;15(2):
pubmed: 29466308
PLoS One. 2018 Oct 24;13(10):e0205239
pubmed: 30356264
Int Perspect Sex Reprod Health. 2013 Jun;39(2):88-96
pubmed: 23895885
Reprod Health. 2019 Feb 19;16(1):20
pubmed: 30782201